Skip to content

Observation on the effect of Zishen Yutong pill on frozen embryo transplantation in patients with hypoovarian function

Observation on the effect of Zishen Yutong pill on frozen embryo transplantation in patients with hypoovarian function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080607
Enrollment
Unknown
Registered
2024-02-02
Start date
2024-02-02
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Decreased ovarian reserve

Interventions

Observation group:Zishen Yutong Pill + Natural cycle/hormone replacement cycle endometrial preparation program
Control group:Natural cycle/hormone replacement cycle endometrial preparation program

Sponsors

Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: ? The diagnostic criteria for ovarian reserve decline were as follows: AMH 20 years old; ?There are transferable embryos (blastocyst or blastocyst) frozen; ? those who meet the dialectical standard of spleen and kidney deficiency in TCM; ? Patients who intend to undergo frozen embryo transplantation; ? Be fully informed and sign informed consent on whether to take oral Zishenyu pill.

Exclusion criteria

Exclusion criteria: ? Patients with uterine malformations, adenomyosis, endometriosis, severe uterine fibroids, hydrosalpinx, moderate to severe uterine adhesives, endometrial tuberculosis, and abnormal uterine morphology; ? Acute and chronic inflammation of reproductive tract; ? Abnormal semen of husband; ? Patients who have received Chinese and Western medicine treatment within the past 1 month; ? Those who have participated in other clinical trials within 1 month; ? Patients with drug allergy in this study; ? Liver and kidney insufficiency.

Design outcomes

Primary

MeasureTime frame
Endometrial receptivity;Pregnancy outcome;

Secondary

MeasureTime frame
Uterine artery blood flow index;Endometrium thickness;

Countries

China

Contacts

Public ContactWang Dejing

Affiliated Hospital of Zunyi Medical University

2430085462@qq.com+86 139 8424 2677

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026